Patient specific computational modeling of fluid-structure interactions of cerebrospinal fluid for biomarkers in Alzheimer's disease
Patient specific computational modeling of fluid-structure interactions of cerebrospinal fluid for biomarkers in Alzheimer's disease
批准号:
10644281
负责人:
Patrick Fillingham
金额:
$30.36万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-30 至 2025-09-29
关键词:
4D MRIAlzheimer&aposs DiseaseAlzheimer&aposs disease diagnosisAlzheimer&aposs disease pathologyAlzheimer&aposs disease patientAnatomyAreaBenchmarkingBiological MarkersBloodBlood flowBrainBrain MappingCarotid ArteriesCerebral aqueductCerebrospinal FluidCerebrumComputer ModelsCoupledDataDevelopmentDiseaseEarly DiagnosisEnsureEvolutionExcisionFrustrationGeometryImageImpairmentIndividualIntracranial PressureLinkLiquid substanceLiteratureMRI ScansMagnetic ResonanceMagnetic Resonance AngiographyMagnetic Resonance ElastographyMagnetic Resonance ImagingMapsMeasurementMeasuresMethodologyMethodsModelingModulusMorbidity - disease rateMulticenter StudiesNeurofibrillary TanglesPathway interactionsPatientsPhasePhlebographyPhysiologicalPlayPopulationProceduresPropertyProteinsProtocols documentationPublic HealthResearchResolutionRoleScanningStressStructural ModelsStructureStructure of jugular veinSubarachnoid SpaceTechniquesTest ResultThird ventricle structureTimeTissuesValidationVenousWorkamyloid peptidebasilar arterybrain tissuecerebrospinal fluid flowcohortcraniumdisease diagnosisforamen magnumhealthy volunteerin vivomechanical propertiesmortalitynovelpotential biomarkerresidencesimulationspatiotemporaltau-1tooltrendvibration
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Alzheimer's Disease has become a daunting public health concern with devastating effects on the
individual and societal level. Early detection and diagnosis of the disease would be incredibly beneficial in the
effort to reduce morbidity and mortality of the disease, yet reliable methods of early detection remain
frustratingly elusive. Recent work has shown impairment of cerebrospinal fluid (CSF) flow in and around the
brain, and how that impairment is linked to brain tissue stiffness, play a vital role in the early development of
Alzheimer's Disease pathology. Unfortunately, existing candidates for measuring CSF flow and brain tissue
stiffness are either highly invasive or semiquantitative analyses that cannot quantify key mechanical properties
of brain tissue deformation and how it relates to the convective transport of AD-related proteins (such as
amyloid -peptide and phosphorylated tau) via CSF flow. To overcome these obstacles, we will develop a
computational model capable of accurately calculating CSF velocities and the stress-strain status of the
brain cortex. Our approach will use state of the art, non-invasive MRI scans in concert with patient-specific
computational fluid dynamic (CFD) modeling of CSF and blood flow to determine the physiological conditions
of flow in the skull and their interactions with brain tissue. To account for the deformation of brain tissue and
the resulting effects on fluid transport, the fluid simulations will be coupled with a structural model of the brain
tissue via fluid-structure interaction (FSI) modeling. The results from this technique will allow for the
development of novel, noninvasive and quantitative biomarkers such as brain "stiffness" (a surrogate for the
hallmark histopathological plaques and tangles), CSF residence time in the subarachnoid space (related to
protein-removal rates), and other hydrodynamic factors such as intracranial pressure pulsatility.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文